home / stock / cron / cron news


CRON News and Press, Cronos Group Inc. From 06/10/21

Stock Information

Company Name: Cronos Group Inc.
Stock Symbol: CRON
Market: NASDAQ
Website: thecronosgroup.com

Menu

CRON CRON Quote CRON Short CRON News CRON Articles CRON Message Board
Get CRON Alerts

News, Short Squeeze, Breakout and More Instantly...

CRON - Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits

Palm Beach, FL – June 10, 2021 – Cannabidiol (CBD) extract is a product that’s derived from cannabis. It’s a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana plants, CBD doesn’t create a ...

CRON - 3 Pot Plays That Are Lighting Up With Momentum

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Look alive, momentum lovers. Despite the broad market’s dithering, marijuana stocks are finally percolating. The awakening has been a long time coming, and today we’re going to spotlight three picks that deman...

CRON - Weed Stocks That Are Major Disappointments in 2021

New Frontier Data mentions cannabis as a fast-growing industry. Its recent report project sales in the U.S. to grow by 21% annually from 2019 to 2025. However, this year’s performance of weed stocks is lackluster and investors aren’t making hay, even in industry leaders. ...

CRON - PSY: 14 Things to Know About the First Psychedelic Stocks ETF in the U.S.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PSY (NYSEARCA: PSY ) is getting extra attention on Monday as investors seek out investments in the psychedelic medical market. Source: luckakcul / Shutterstock.com Here’s everything investors interested...

CRON - Merus upgraded on ASCO update, Citi favors Harpoon after selloff; and more in today's analyst action

Photo by goir/iStock via Getty Images Merus jumps on Citi upgrade Merus (MRUS) shares have climbed ~5.4% in early trading after Citi analyst Yigal Nochomovitz upgraded the stock to buy from neutral. The price target of $31.00 per share implies a premium of ~49.9%. Citing dataset pre...

CRON - Investor Ideas Potcasts #572, Cannabis News and Stocks on the Move

Delta, Kelowna, BC - June 4, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight...

CRON - Up 20% Over a Few Days, Is Cronos a Stock You Can Count On?

Cronos Group (NASDAQ: CRON) was once a prominent cannabis grower that has seen its fortune slide downhill since early 2019. Its strategy of focusing on research & development and selling cannabidiol (CBD) did not work out well in an industry dominated by high-concentration...

CRON - Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG

BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for cell program...

CRON - Delivery Service Market is One of the Hottest Revenue Streams In Cannabis Industry

Palm Beach, FL – June 3, 2021 – Over the past few years the legalization of marijuana has spurred the industry’s growth in both medicinal and recreational markets… and the growth appears that it will continue to substantially rise in the years to come. The cannab...

CRON - Cronos, Organigram and HEXO fall after Canopy Growth missed estimates

Canadian cannabis stocks, Cronos Group ([[CRON]] -7.8%), OrganiGram Holdings ([[OGI]] -6.9%) and HEXO ([[HEXO]] -4.3%) have joined Canopy Growth ([[CGC]] -3.6%) to lose sharply in morning hours after the latter disappointed with its Q4 results for fiscal 2021.Revenue for full-year FY21 a...

Previous 10 Next 10